Selected Publications using Genemed's LipoGene™ Transfection Reagent

Publications Link to the article Products/Services
X. Ma, ‘Hippo Signaling Promotes Jnk-Dependent Cell Migration’, Proc Natl Acad Sci U S A, 114 (2017), 1934-39. LipoGene™ Transfection Reagent
Y. Li, ‘A Novel Epigenetic Aml1-Eto/Thap10/Mir-383 Mini-Circuitry Contributes to T(8;21) Leukaemogenesis’, EMBO Mol Med, 9 (2017), 933-49. LipoGene™ Transfection Reagent
Z. Yang, ‘A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase Rop18’, Mol Cell Proteomics, 16 (2017), 469-84. LipoGene™ Transfection Reagent
X. Zhang, ‘Long Non-Coding Rna Ufc1 Promotes Gastric Cancer Progression by Regulating Mir-498/Lin28b’, J Exp Clin Cancer Res, 37 (2018), 134. LipoGene™ Transfection Reagent
G. Deng, ‘Bmp4 Promotes Hepatocellular Carcinoma Proliferation by Autophagy Activation through Jnk1-Mediated Bcl-2 Phosphorylation’, J Exp Clin Cancer Res, 37 (2018), 156. LipoGene™ Transfection Reagent
H. Zhang, ‘Caf-Secreted Cxcl1 Conferred Radioresistance by Regulating DNA Damage Response in a Ros-Dependent Manner in Esophageal Squamous Cell Carcinoma’, Cell Death Dis, 8 (2017), e2790. LipoGene™ Transfection Reagent
Y. He, ‘Adeno-Associated Virus 9-Mediated Cdk5 Inhibitory Peptide Reverses Pathologic Changes and Behavioral Deficits in the Alzheimer’s Disease Mouse Model’, FASEB J, 31 (2017), 3383-92. LipoGene™ Transfection Reagent
N. Wang, ‘Direct Inhibition of Actn4 by Ellagic Acid Limits Breast Cancer Metastasis Via Regulation of Beta-Catenin Stabilization in Cancer Stem Cells’, J Exp Clin Cancer Res, 36 (2017), 172. LipoGene™ Transfection Reagent
D. S. Wu, ‘Atf2 Predicts Poor Prognosis and Promotes Malignant Phenotypes in Renal Cell Carcinoma’, J Exp Clin Cancer Res, 35 (2016), 108. LipoGene™ Transfection Reagent
L. Liu, ‘Synthetic Bax-Anti Bcl2 Combination Module Actuated by Super Artificial Htert Promoter Selectively Inhibits Malignant Phenotypes of Bladder Cancer’, J Exp Clin Cancer Res, 35 (2016), 3. LipoGene™ Transfection Reagent
Y. Zhang, ‘Clinical Significance and Effect of Aeg-1 on the Proliferation, Invasion, and Migration of Nsclc: A Study Based on Immunohistochemistry, Tcga, Bioinformatics, in Vitro and in Vivo Verification’, Oncotarget, 8 (2017), 16531-52. LipoGene™ Transfection Reagent
L. Liu, ‘Inhibiting Cell Migration and Cell Invasion by Silencing the Transcription Factor Ets-1 in Human Bladder Cancer’, Oncotarget, 7 (2016), 25125-34. LipoGene™ Transfection Reagent
W. Li, ‘Mirna-99b-5p Suppresses Liver Metastasis of Colorectal Cancer by Down-Regulating Mtor’, Oncotarget, 6 (2015), 24448-62. LipoGene™ Transfection Reagent
S. Wen, ‘P53 Increase Mitochondrial Copy Number Via up-Regulation of Mitochondrial Transcription Factor a in Colorectal Cancer’, Oncotarget, 7 (2016), 75981-95. LipoGene™ Transfection Reagent
C. Du, ‘Polyethyleneimine-Capped Silver Nanoclusters for Microrna Oligonucleotide Delivery and Bacterial Inhibition’, Int J Nanomedicine, 12 (2017), 8599-613. LipoGene™ Transfection Reagent
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.